Stockreport

MaaT Pharma Announces Initiation of Coverage of its Stock by Stifel with a Buy Rating and a Target Price of EUR 16 [Yahoo! Finance]

KBC GROUP SA UNSP/ADR  (KBCSY) 
NASDAQ:AMEX Investor Relations: kbc.com/en/investor-relations
PDF company and a leader in the development of Microbiome Ecosystem Therapies TM (MET) dedicated to enhancing survival of patients with cancer, announces the initiation of c [Read more]